Topical steroids versus topical tacrolimus with microneedling in alopecia areata.

A comparison of topical corticosteroids versus topical tacrolimus with microneedling in alopecia areata. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/09/073322

Enrollment

Registered

2024-09-04

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L639- Alopecia areata, unspecified

Interventions

Intervention1: Topical corticosteroids versus topical tacrolimus with microneedling in alopecia areata: One half of the scalp receives topical 0.1% tacrolimus ointment application once daily with 4 se

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed as alopecia areata. Patients = 2 patches of hair loss over scalp. Patients on topical or systemic treatment after washout period of 2 weeks and 4 weeks respectively.

Exclusion criteria

Exclusion criteria: Patients with alopecia totalis/ universalis. Patients with skin atrophy on alopecia patch. Pregnancy/ lactation. Active infection. Patients with comorbidities. Hemophilias/ bleeding tendency. Tendency for scarring/ keloid formation.

Design outcomes

Primary

Measure	Time frame
1. Efficacy of topical tacrolimus with microneedling in alopecia areata using SALT score and dermascopy. Timepoint: 1 year	—

Secondary

Measure	Time frame
Comparative efficacy of topical tacrolimus with microneedling versus topical corticosteroids in alopecia areata.Timepoint: 1 year	—

Countries

India

Contacts

Public ContactRajesh Kumar

Maulana Azad Medical College

kdebbarman@yahoo.com9868961716

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026